United States - English - NLM (National Library of Medicine)

r.a. mcneil company - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn) - codeine phosphate 6.33 mg in 5 ml - temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: - cough due to minor throat and bronchial irritation - nasal congestion - itching of nose or throat - runny nose - itchy, watery eyes - sneezing - reduces swelling of nasal passages

United States - English - NLM (National Library of Medicine)

cypress pharmaceutical, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - hydrocodone bitartrate, pseudoephedrine hydrochloride, and chlorpheniramine maleate is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. - contraindicated in pediatric patients less than 6 years of age [see contraindications (4) ]. - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1) ], reserve hydrocodone bitartrate, pseudoephedrine hydrochloride, and chlorpheniramine maleate for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made. hydrocodone bitartrate, pseudoephedrine hydrochloride, and chlorpheniramine maleate is contraindicated for: -

Namibia - English - Namibia Medicines Regulatory Council

alliance pharma (pty) ltd - codeine phosphate , chlorpheniramine maleate, sodium salycylate, guaiphenesin , phenylephrinhcl, cetylpyridium chloride , caffeine - syrup - each 5ml syrup contains: codeine phosphate 5mg, chlorpheniramine maleate 2mg, sodium salycylate 150mg, guaiphenesin 25mg, phenyl

United States - English - NLM (National Library of Medicine)

lannett company, inc. - codeine sulfate (unii: 11qv9bs0cb) (codeine anhydrous - unii:ux6owy2v7j) - codeine sulfate 15 mg - codeine sulfate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [ s ee warnings and precautions ( 5.1 ) ] , reserve codeine sulfate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - have not been tolerated, or are not expected to be tolerated. have not been tolerated, or are not expected to be tolerated. - have not provided adequate analgesia, or are not expected to provide adequate analgesia. have not provided adequate analgesia, or are not expected to provide adequate analgesia. codeine sulfate tablets are contraindicated for: - all children younger than 12 years of age [see warnings and precautions ( 5.4 )] . - post-operative management in children younger than 18 years of age following tonsillect

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - chlorpheniramine maleate; dextromethorphan hydrobromide; ephedrine hydrochloride - oral solution/suspension - chlorpheniramine maleate antihistamine active 0.4 mg/ml; dextromethorphan hydrobromide alkaloid active 2.0 mg/ml; ephedrine hydrochloride alkaloid active 1.0 mg/ml - respiratory system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - cough suppression | bronchitis | bronchodilation | cough suppressants | decongestants | expectorants | mucoid secretions | mucolytics | respiratory conditions | sinusitis

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - doxylamine succinate, quantity: 5.1 mg; codeine phosphate hemihydrate, quantity: 10 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; purified talc; magnesium stearate; pregelatinised maize starch; sodium lauryl sulfate; colloidal anhydrous silica; hyprolose; stearic acid - for the temporary relief of acute moderate pain

Canada - English - Health Canada

mcneil consumer healthcare division of johnson & johnson inc - acetaminophen; pseudoephedrine hydrochloride; chlorpheniramine maleate; codeine phosphate - tablet - 325mg; 30mg; 2mg; 8mg - acetaminophen 325mg; pseudoephedrine hydrochloride 30mg; chlorpheniramine maleate 2mg; codeine phosphate 8mg - antitussives

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - codeine sulfate (unii: 11qv9bs0cb) (codeine - unii:q830pw7520) - codeine sulfate 60 mg - codeine sulfate is an opioid analgesic indicated for the relief of mild to moderately severe pain where the use of an opioid analgesic is appropriate. codeine sulfate is contraindicated in patients with known hypersensitivity to codeine or any components of the product. persons known to be hypersensitive to certain other opioids may exhibit cross-sensitivity to codeine. codeine sulfate is contraindicated in patients with respiratory depression in the absence of resuscitative equipment. codeine sulfate is contraindicated in patients with acute or severe bronchial asthma or hypercarbia. codeine sulfate is contraindicated in any patient who has or is suspected of having paralytic ileus. enter section text here codeine sulfate is an opioid agonist and is a schedule ii controlled substance. codeine sulfate can be abused and is subject to criminal diversion.  drug addiction is characterized by compulsive use, use for non-medical purposes, and continued use despite harm or risk of harm. drug addiction is

United States - English - NLM (National Library of Medicine)

aytu biopharma, inc. - codeine phosphate anhydrous (unii: 2x585m1m3t) (codeine - unii:q830pw7520), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - tuzistra xr is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older.tuzistra xr is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. important limitations of use - not indicated for pediatric patients under 18 years of age [ ]. not indicated for pediatric patients under 18 years of age [ see use in specific populations (8.4) ]. not indicated for pediatric patients under 18 years of age [ ]. not indicated for pediatric patients under 18 years of age [ see use in specific populations (8.4) ]. - contraindicated in pediatric patients under 12 years of age [ see contraindications (4),use in specific populations (8.4) ]. contraindicated in pedi

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - chlorpheniramine maleate, codeine phosphate, glyceryl guaiacolate, liquorice - syrup